185 related articles for article (PubMed ID: 2502974)
1. Absorption of valproic acid suppositories in human volunteers.
Holmes GB; Rosenfeld WE; Graves NM; Remmel RP; Carlson GH; Kriel RD
Arch Neurol; 1989 Aug; 46(8):906-9. PubMed ID: 2502974
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical evaluation of hollow type suppositories. V. Preparation of valproic acid suppository and rectal absorption of valproic acid in rabbits.
Watanabe Y; Tone Y; Nishihara S; Matsumoto M
J Pharmacobiodyn; 1986 Dec; 9(12):953-61. PubMed ID: 3106614
[TBL] [Abstract][Full Text] [Related]
4. Antipyretic therapy. Comparison of rectal and oral paracetamol.
Keinänen S; Hietula M; Similä S; Kouvalainen K
Eur J Clin Pharmacol; 1977 Aug; 12(1):77-80. PubMed ID: 332506
[TBL] [Abstract][Full Text] [Related]
5. Influence of the hydrophilicity of suppository bases on rectal absorption of carprofen, a lipophilic nonsteroidal anti-inflammatory drug.
Schmitt M; Guentert TW
J Pharm Sci; 1990 Apr; 79(4):359-63. PubMed ID: 2352151
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of rectally administered valproic acid syrup.
Cloyd JC; Kriel RL
Neurology; 1981 Oct; 31(10):1348-52. PubMed ID: 6810203
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion.
VanDenBerg CM; Kazmi Y; Stewart J; Weidler DJ; Tenjarla SN; Ward ES; Jann MW
Am J Health Syst Pharm; 2000 Jun; 57(11):1046-50. PubMed ID: 10876746
[TBL] [Abstract][Full Text] [Related]
8. Rectal bioavailability of water-soluble drugs: sodium valproate.
Margarit MV; Rodríguez IC; Cerezo A
J Pharm Pharmacol; 1991 Oct; 43(10):721-5. PubMed ID: 1682448
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
10. Rectal administration of sodium valproate in status epilepticus.
Vajda FJ; Mihaly GW; Miles JL; Donnan GA; Bladin PF
Neurology; 1978 Sep; 28(9 Pt 1):897-9. PubMed ID: 358013
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
12. Oral versus rectal ibuprofen in healthy volunteers.
Vilenchik R; Berkovitch M; Jossifoff A; Ben-Zvi Z; Kozer E
J Popul Ther Clin Pharmacol; 2012; 19(2):e179-86. PubMed ID: 23238355
[TBL] [Abstract][Full Text] [Related]
13. Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms.
Moolenaar F; Greving WJ; Huizinga T
Eur J Clin Pharmacol; 1980 Apr; 17(4):309-15. PubMed ID: 6772450
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
Bano G; Gupta S; Gupta KL; Raina RK
J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children.
Issakainen J; Bourgeois BF
Eur J Pediatr; 1987 Jul; 146(4):404-7. PubMed ID: 3115782
[TBL] [Abstract][Full Text] [Related]
16. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of ethionamide suppositories.
Peloquin CA; James GT; McCarthy E; Goble M
Pharmacotherapy; 1991; 11(5):359-63. PubMed ID: 1745621
[TBL] [Abstract][Full Text] [Related]
18. Rectal absorption of ozagrel from a suppository containing its commercial tablet in healthy human subjects.
Zheng NX; Sato H; Kobayashi F; Masuko Y; Adachi I; Horikoshi I
Biol Pharm Bull; 1997 Mar; 20(3):282-4. PubMed ID: 9084888
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
Ellison NM; Lewis GO
Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
[TBL] [Abstract][Full Text] [Related]
20. Pentobarbital absorption from capsules and suppositories in humans.
Doluisio JT; Smith RB; Chun AH; Dittert LW
J Pharm Sci; 1978 Nov; 67(11):1586-8. PubMed ID: 712597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
